DOI QR코드

DOI QR Code

Comparison of Steroid Treatment with and without Hyperbaric Oxygen Therapy for Idiopathic Sudden Sensorineural Hearing Loss

  • Yucel, Abitter (Department of Otorhinolaryngology Head and Neck Surgery, Konya Health Application and Research Center, University of Health Sciences Turkey) ;
  • Ozbugday, Yasar (Department of Otorhinolaryngology Head and Neck Surgery, Konya Training and Research Hospital, University of Health Sciences Turkey)
  • Received : 2019.12.12
  • Accepted : 2020.02.21
  • Published : 2020.07.20

Abstract

Background and Objectives: In this study, we compared the outcomes of patients with idiopathic sudden sensorineural hearing loss who underwent steroid treatment with or without hyperbaric oxygen (HBO) therapy and were followed-up in our clinic. Subjects and Methods: Patients were divided into two groups according to their treatment regimen. Steroid group received intravenous 1 mg/kg methylprednisolone which was due to be completed in 2-3 weeks with decreasing doses, and five doses of 0.5 mL intratympanic dexamethasone. Steroid+HBO group received the same steroid treatment with the addition of HBO therapy. The audiologic results of both treatment groups were compared after considering the patients' risk factors. Results: There was no significant difference between the steroid and Steroid+HBO groups in terms of hearing gain and degree of recovery, both at all degrees of hearing loss, and in severe and profound hearing loss. Hearing gain was similar when evaluated by audiogram type and admission time in both treatment groups. Conclusions: We found that the addition of HBO therapy to systemic plus intratympanic steroid treatment did not affect hearing gain at all degrees of hearing loss in this study. Furthermore, audiogram type and admission time did not affect hearing gain between the two groups.

Keywords

References

  1. Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984;94(5 Pt 1):647-61.
  2. Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol 1999;20:587-92; discussion 593-5.
  3. Eisenman D, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:1161-4. https://doi.org/10.1001/archotol.126.9.1161
  4. Quaranta N, Ramunni A, De Luca C, Brescia P, Dambra P, De Tullio G, et al. Endothelial progenitor cells in sudden sensorineural hearing loss. Acta Otolaryngol 2011;131:347-50. https://doi.org/10.3109/00016489.2010.536990
  5. Toroslu T, Erdogan H, Caglar O, Guclu O, Derekoy FS. Comparison of different treatment methods for idiopathic sudden sensorineural hearing loss. Turk Arch Otorhinolaryngol 2018;56:226-32.
  6. Korpinar S, Alkan Z, Yigit O, Gor AP, Toklu AS, Cakir B, et al. Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 2011;268:41-7. https://doi.org/10.1007/s00405-010-1336-6
  7. Labus J, Breil J, Stutzer H, Michel O. Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope 2010;120:1863-71. https://doi.org/10.1002/lary.21011
  8. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(3 Suppl):S1-35. https://doi.org/10.1177/0194599812436449
  9. Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833-40. https://doi.org/10.1056/NEJMcp0802129
  10. Topuz E, Yigit O, Cinar U, Seven H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol 2004;261:393-6.
  11. Stokroos RJ, Albers FW. The etiology of idiopathic sudden sensorineural hearing loss. A review of the literature. Acta Otorhinolaryngol Belg 1996;50:69-76.
  12. Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2007;264:861-6. https://doi.org/10.1007/s00405-007-0272-6
  13. Suzuki H, Hashida K, Nguyen KH, Hohchi N, Katoh A, Koizumi H, et al. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 2012;122:1154-7. https://doi.org/10.1002/lary.23245
  14. Appaix A, Demard F. [Hyperbaric oxygenotherapy and sudden perceptive deafness]. Rev Laryngol Otol Rhinol (Bord) 1970;91:951-72.
  15. Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 1998;54:86-99.
  16. Goto F, Fujita T, Kitani Y, Kanno M, Kamei T, Ishii H. Hyperbaric oxygen and stellate ganglion blocks for idiopathic sudden hearing loss. Acta Otolaryngol 1979;88:335-42. https://doi.org/10.3109/00016487909137177
  17. Pezzoli M, Magnano M, Maffi L, Pezzoli L, Marcato P, Orione M, et al. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study. Eur Arch Otorhinolaryngol 2015;272:1659-66. https://doi.org/10.1007/s00405-014-2948-z
  18. Bayoumy AB, de Ru JA. The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review. Eur Arch Otorhinolaryngol 2019;276:1859-80. https://doi.org/10.1007/s00405-019-05469-7
  19. Edizer DT, Celebi O, Hamit B, Baki A, Yigit O. Recovery of idiopathic sudden sensorineural hearing loss. J Int Adv Otol 2015;11:122-6. https://doi.org/10.5152/iao.2015.1227
  20. Ergun Tasdoven G, Derin AT, Yaprak N, Ozcaglar Hu. The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss. Braz J Otorhinolaryngol 2017;83:457-63. https://doi.org/10.1016/j.bjorl.2016.06.002
  21. Cho I, Lee HM, Choi SW, Kong SK, Lee IW, Goh EK, et al. Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Audiol Neurootol 2018;23:199-207. https://doi.org/10.1159/000493558
  22. Eryigit B, Ziylan F, Yaz F, Thomeer HGXM. The effectiveness of hyperbaric oxygen in patients with idiopathic sudden sensorineural hearing loss: a systematic review. Eur Arch Otorhinolaryngol 2018;275:2893-904. https://doi.org/10.1007/s00405-018-5162-6
  23. Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg 2019;161(1_suppl):S1-45. https://doi.org/10.1177/0194599819859885